Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277857 · ClinicalTrials.gov registry record
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome
A clinical trial of Nontuberculous Mycobacterial Lung Disease, sponsored by University of Virginia.
- Recruiting
- Registry status
- 720
- Enrollment target
- 1
- Study location
NCT05277857: Recruiting study of Nontuberculous Mycobacterial Lung Disease, sponsored by University of Virginia.
NCT05277857 is a study of Nontuberculous Mycobacterial Lung Disease that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 720 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05277857, a study of Nontuberculous Mycobacterial Lung Disease, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 720 participants
- Enrollment target
- 1
- Study location
Study Summary
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
Primary Outcome
Relapse versus reinfection: Perform whole genome sequencing of NTM isolates from lung disease patients from across Virginia to discern relapse versus reinfection and environmental sources of acquisition.
Conditions Studied
Study Locations (1)
Virginia
- University of Virginia, Division of Infectious Disease - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2020-09-20 |
| Est. Completion | 2026-12-31 |
What NCT05277857 shows while recruiting
NCT05277857 is an observational study that tracks outcomes without assigning an intervention. The registered 720 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Nontuberculous Mycobacterial Lung Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05277857 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05277857 about?
NCT05277857 is a clinical study titled "Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome". Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
What is the current status of trial NCT05277857?
This trial is currently recruiting. The enrollment target is 720 participants. The study started on 2020-09-20. Estimated completion is 2026-12-31.
What conditions does trial NCT05277857 study?
This clinical trial studies the following conditions: Nontuberculous Mycobacterial Lung Disease.
Who is sponsoring clinical trial NCT05277857?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05277857 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nontuberculous Mycobacterial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
- NCT05047224 · 720 participants · NA
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool
- NCT05309395 · 720 participants · Phase 3
Food Prescriptions to Promote Affordable Diets
- NCT05466214 · 720 participants · NA
Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI